Eli Lilly Lowers Weight-Loss Drug Zepbound Prices After Trump Deal
Forbes·2025-12-01 14:50

The pharmaceutical giant and Novo Nordisk said they would lower the prices of their popular weight loss drugs to expand access.Eli Lilly on Monday lowered the cost of Zepbound after the pharmaceutical giant and Ozempic maker Novo Nordisk announced a deal with the Trump administration to slash the prices of the popular weight-loss drugs.The out-of-pocket monthly price for the lowest single-dose vial of Zepbound is now $299 when purchased through Eli Lilly’s platform LillyDirect, a 14% decrease from $349, whi ...